MedTrace Logo

Homocysteine and Progression of Atherosclerosis

NCT00005338 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2016-02-18

No results posted yet for this study

Summary

In the first phase, to establish the relationship of progression of peripheral vascular disease (PVD) to plasma homocysteine. In the second phase, to conduct a randomized, controlled trial of folic acid treatment of plasma homocysteine in peripheral vascular disease.

Conditions

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Lloyd Taylor · Oregon Health and Science University

Eligibility

Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1991-08-31
Completion
2004-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00005338 on ClinicalTrials.gov